These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25974193)

  • 1. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes.
    Xiong Q; Proietti M; Senoo K; Lip GY
    Int J Cardiol; 2015 Jul; 191():172-7. PubMed ID: 25974193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Marzona I; Proietti M; Farcomeni A; Romiti GF; Romanazzi I; Raparelli V; Basili S; Lip GYH; Nobili A; Roncaglioni MC
    Int J Cardiol; 2018 Oct; 269():182-191. PubMed ID: 30025657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
    Barra S; Baran J; Narayanan K; Boveda S; Fynn S; Heck P; Grace A; Agarwal S; Primo J; Marijon E; Providência R
    Int J Cardiol; 2018 Sep; 266():136-142. PubMed ID: 29887429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study.
    Potpara TS; Marinkovic JM; Polovina MM; Stankovic GR; Seferovic PM; Ostojic MC; Lip GY
    Int J Cardiol; 2012 Nov; 161(1):39-44. PubMed ID: 21570138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Sinagra G; Petrescu L; Tavazzi L; Maggioni AP; Lip GY
    Am J Med; 2015 May; 128(5):509-18.e2. PubMed ID: 25534423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
    Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review.
    Zhu W; Guo L; Hong K
    Int J Cardiol; 2016 Nov; 222():289-294. PubMed ID: 27500755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study.
    Rienstra M; Vermond RA; Crijns HJ; Tijssen JG; Van Gelder IC;
    Heart Rhythm; 2014 Jun; 11(6):939-45. PubMed ID: 24632222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
    Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
    Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications.
    Siontis KC; Gersh BJ; Killian JM; Noseworthy PA; McCabe P; Weston SA; Roger VL; Chamberlain AM
    Heart Rhythm; 2016 Jul; 13(7):1418-24. PubMed ID: 26961300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
    Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Gundlund A; Fosbøl EL; Kim S; Fonarow GC; Gersh BJ; Kowey PR; Hylek E; Mahaffey KW; Thomas L; Piccini JP; Peterson ED;
    Am Heart J; 2016 May; 175():28-35. PubMed ID: 27179721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.
    Bang CN; Greve AM; Abdulla J; Køber L; Gislason GH; Wachtell K
    Int J Cardiol; 2013 Aug; 167(3):624-30. PubMed ID: 22999824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey.
    Guerra F; Brambatti M; Nieuwlaat R; Marcucci M; Dudink E; Crijns HJGM; Matassini MV; Capucci A
    Europace; 2017 Dec; 19(12):1922-1929. PubMed ID: 29106537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
    Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.